A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes

This study has been completed.
Sponsor:
Information provided by:
Mirati Therapeutics Inc.
ClinicalTrials.gov Identifier:
NCT00324194
First received: May 8, 2006
Last updated: January 6, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)